Works Cited
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
4. Copstead-Kirkhorn LE, Banasik JL. Pathophysiology. 6th ed. St. Louis, MO: Elsevier Health Sciences; 2019.
5. Mitchell R. Pocket Companion to Robbins and Cotran Pathologic Basis of Disease. 9th ed. Philadelphia, PA: Elsevier; 2017.
6. Avram M, Kiahr S. Renal Disease Progression and Management: Role of Vasoactive Agents, Cytokines, Lipids, and Nutrition. Philadelphia, PA: Elsevier Health Sciences; 1996.
8. Xin JZ, Laszidk ZG, Nadasdy T, D'Agati VD. Silva's Diagnostic Renal Pathology. 2nd ed. Cambridge: Cambridge University Press; 2018.
10. Nowak T. Pathophysiology: Concepts and Applications for Health Care Professionals. 2nd ed. Boston, MA: McGraw-Hill; 1999.
11. Rennke H, Denton M, Magee C. Renal Disease: Prevention and Treatment. New York, NY: CRC Press; 1998.
12. Johnson G. On the Diseases of the Kidney, Their Pathology, Diagnosis, and Treatment. London: J.W. Parker and Son; 1852.
13. Clark WB. The Diagnosis and Treatment of Diseases of the Kidney Amenable to Direct Surgical Interference. London: Lewis Publishing; 1886.
14. Wilcox CS. Therapy in Nephrology and Hypertension: A Companion to Brenner and Rector's The Kidney. 3rd ed. Philadelphia, PA: Saunders/Elsevier; 2008.
15. Moorthy V. Pathophysiology of Kidney Disease and Hypertension. Philadephia, PA: Elsevier Health Sciences; 2009.
16. Brenner BM, Coe FL, Rector FC. Renal Physiology in Health and Disease. Philadelphia, PA: Elsevier Health Sciences; 1987.
17. Gonick HC, Buckalew VM. Renal Tubular Disorders: Pathophysiology, Diagnosis and Management. New York, NY: Marcel Dekker; 1985.
20. McCance KL, Felver L. Pathophysiology: The Biologic Basis for Disease in Adults and Children. 8th ed. St. Louis, MO: Elsevier Health Sciences; 2018.
22. Humes HD. Pathophysiology of Electrolyte and Renal Disorders. New York, NY: Churchill Livingstone; 1986.
23. Tisher CC, Brenner BM. Renal Pathology with Clinical and Functional Correlations. 2nd ed. Philadelphia, PA: Lippincott, Williams, and Wilkins; 1994.
24. Price SA. Pathophysiology: Clinical Concepts of Disease Processes. 7th ed. St. Louis, MO: Mosby; 2014.
26. Brashers VL. Clinical Applications of Pathophysiology: Assessment, Diagnostic Reasoning and Management. 2nd ed. St. Louis, MO: Mosby; 2002.
27. Black J, Hawks JH, Keene AM. Medical Surgical Nursing: Clinical Management for Continuity of Care. 8th ed. Philadelphia, PA: W.B Saunders, 2011.
28. LeMone P, Burke KM, Bauldoff G. Medical-Surgical Nursing: Critical Thinking in Patient Care. 5th ed. Upper Saddle River, NJ: Prentice Hall; 2014.
29. Ginès P. Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment. Walden, MA: Blackwell; 2005.
30. Suki WN, Eknoyan G. The Kidney in Systemic Disease. New York, NY: Wiley, John and Sons, Inc.; 1981.
32. Al-Shaikh TM, Alkaseb KS, Mudawi MME, Yassin AYA, Habeballa RS, Alzain SD. Toxicological studies on commercial hair dye brand commonly used in Saudi Arabia: histological study of the liver, kidney, heart, and testis. J Basic Appl Zoology. 2018;79:22.
33. Ackley BJ, Ladwig GB, Flynn Makic MB, Martinez-Kratz MR, Zanotti M. Nursing Diagnosis Handbook: An Evidence-Based Guide to Planning Care. 12th ed. St. Louis, MO: Elsevier; 2020.
34. Ladwig GE, Ackley BJ, Flynn Makic MB, Martinez-Kratz MR, Zanotti M. Mosby's Guide to Nursing Diagnosis. 6th ed. St. Louis, MO: Elsevier; 2020.
36. Zerwekh, JG, Claborn JC, Gaglione T, Gameau AZ, Souter S. Mosby's Pharmacology Memory NoteCards: Visual, Mnemonic, and Memory Aids for Nurses. 3rd ed. Philadelphia, PA: Elsevier Mosby; 2011.
37. Mount DB, Pollak MR. Molecular and Genetic Basis of Renal Disease. Philadelphia, PA: Elsevier Health Sciences; 2008.
40. McDougal WS, Wein AJ, Kavoussi LR, Partin AW, Peters C. Campbell-Walsh Urology 11th Edition Review. 2nd ed. Philadelphia, PA: Elsevier; 2015.
41. Bihl GR, Petri M, Fine DM. Kidney biopsy in lupus nephritis: look before you leap. Nephrol Dial Transplant. 2006;21(7):1749-1752.
42. Blake MA, Sweeney AT. Pheochromocytoma. Available at https://emedicine.medscape.com/article/124059-overview. Last accessed June 28, 2023.
43. Ferrell BR, Paice JA. Oxford Textbook of Palliative Nursing. 5th ed. New York, NY: Oxford University Press; 2019.
45. Lederer E, Alsauskas ZC, Mackelaite L, Nayak V. Hyperkalemia. Available at https://emedicine.medscape.com/article/240903-overview. Last accessed June 28, 2023.
46. Kasper DL, Braunwald E, Hauser S, Longo D, Jameson JL, Fauci AS. Harrison's Principles of Internal Medicine. 19th ed. New York, NY: McGraw-Hill; 2015.
48. Wu Y, Fu YY, Zhu HD, Xu J, Walline JH. Treatment of hyperkalemic emergencies. World J Emerg Med. 2022;13(3):232-236.
49. Sterns RH, Rojas M, Bernstein P, Chennupati S. Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective?J Am Soc Nephrol. 2010;21(5):733-735.
50. Tamargo J. New Drugs for the Treatment of Hyperkalemia in Patients Treated with Renin-Angiotensin-Aldosterone System Inhibitors: Hype or Hope? Available at https://www.discoverymedicine.com/Juan-Tamargo/2014/11/new-drugs-for-the-treatment-of-hyperkalemia-in-patients-treated-with-renin-angiotensin-aldosterone-system-inhibitors-hype-or-hope. Last accessed June 28, 2023.
52. DiPiro JT. Pharmacotherapy A Pathophysiologic Approach. 11th ed. New York, NY: McGraw Hill Medical; 2020.
53. Longo DL, Kasper DL, Jameson JL, et al. Harrison's Principles of Internal Medicine. 19th ed. New York, New York: McGraw-Hill; 2015.
54. Malhotra D, Tzamaloukas AH. Non-dialysis management of chronic renal failure. Med Clin North Am. 1997;81(3):749-766.
55. Skorecki K, Chertow GM, Marsden PA, Taal MW, Yu ASL. Brenner and Rector's The Kidney. 10th ed. Philadelphia, PA: Saunders; 2015.
56. International Society of Nephrology. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Available at https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf. Last accessed June 28, 2023.
57. NKF KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Available at https://www.kidney.org/sites/default/files/docs/ckd_evaluation_classification_stratification.pdf. Last accessed June 28, 2023.
58. Centers for Medicare and Medicaid Services. Medicare Coverage of Kidney Dialysis and Kidney Transplant Services. Available at https://www.medicare.gov/Pubs/pdf/10128-Medicare-Coverage-ESRD.pdf. Last accessed June 28, 2023.
59. Centers for Disease Control and Prevention. National Chronic Kidney Disease Fact Sheet, 2017. Atlanta, GA: US Department of Health and Human Services; 2017.
60. Bullock A, Burrows NR, Narva AS, et al. Vital signs: decrease in incidence of diabetes-related end-stage renal disease among American Indians/Alaska Natives—United States, 1996–2013. MMWR. 2017;66(01):26-32.
61. Burrows NR, Li Y, Geiss LS. Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline. Diabetes Care. 2010;33(1):73-77.
62. Whaley-Connell AT, Vassalotti JA, Collins AJ, Chen SC, McCullough PA. National Kidney Foundation's Kidney Early Evaluation Program (KEEP) annual data report 2011: executive summary. Am J Kidney Dis. 2012;59(3 Suppl 2):S1-S4.
63. United States Renal Data System Annual Data Report 2018: Epidemiology of Kidney Disease in the United States. Available at https://www.usrds.org/adr.aspx. Last accessed June 28, 2023.
64. Gross ML, Dikow R, Ritz E. Diabetic nephropathy: recent insights into the pathophysiology and the progression of diabetic nephropathy. Kidney Int. 2005;(94):S50-S53.
65. Shumway JT, Gambert SR. Diabetic nephropathy: pathophysiology and management. Int Urol Nephrol. 2002;34(2):257-264.
66. UK Prospective Diabetes Study Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854-865.
67. Jones J, Holmen J, De Graauw J, Jovanovich A, Thornton S, Chonchol M. Association of complete recovery from acute kidney injury with incident CKD stage 3 and all-cause mortality. Am J Kidney Dis. 2012;60(3):402-408.
68. Hart PD, Bakris GL. Hypertensive nephropathy: prevention and treatment recommendations. Expert Opin Pharmacother. 2010;11(16):2675-2686.
70. Portolés J, Gorriz JL, Rubio E, et al. The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease. BMC Nephrol. 2013;14:2.
71. National Kidney Foundation. KDOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(Suppl 3):S1-S201.
72. Sarafidis PA, Blacklock R, Wood E, et al. Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic. Clin Am J Soc Nephrol. 2012;7(8):1234-1241.
73. Block GA, Ix JH, Ketteler M, et al. Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney Foundation. Am J Kidney Dis. 2013;62(3):457-473.
74. Lanken PN, Terry PB, Delisser HM, et al. An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med. 2008;177(8):912-927.
75. Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345(12):851-860.
76. National Kidney Foundation. KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002;39(Suppl 1):S1-S266.
77. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;3:1-150.
78. American Dietetic Association. Manual of Clinical Dietetics. 6th ed. Chicago, IL: Academy of Nutrition and Dietetics; 2000.
79. London GM. Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant. 2002;17(1):S29-S36.
80. Workeneh BT, Agraharkar M, Gupta R. Acute Kidney Injury. Available at https://emedicine.medscape.com/article/243492-overview. Last accessed June 28, 2023.
81. Huether SE, McCance KL, Brashers VL. Understanding Pathophysiology. 7th ed. St. Louis, MO: Elsevier; 2020.
83. Baird MS. Manual of Critical Care Nursing: Nursing Interventions and Collaborative Management. 7th ed. St. Louis, MO: Mosby; 2016.
84. Norris TL. Porth's Pathophysiology: Concepts of Altered Health States. 10th ed. Philadelphia, PA: Wolters Kluwer; 2019.
85. National Institute of Diabetes and Digestive and Kidney Diseases. National Kidney Disease Education Program. Available at https://www.niddk.nih.gov/health-information/community-health-outreach/information-clearinghouses/nkdep. Last accessed June 28, 2023.
87. Bruyere HJ Jr. 100 Case Studies in Pathophysiology. Philadelphia, PA: Lippincott, Williams and Wilkins: 2009.
88. Berg SM, Bittner EA, Lee J. Massachusetts General Hospital Review of Critical Care Medicine. Philadelphia, PA: Wolters, Kluwer, Lippincott, Williams & Wilkins; 2014.
89. American Cancer Society. Key Statistics About Kidney Cancer. Available at https://www.cancer.org/cancer/kidney-cancer/about/key-statistics.html. Last accessed June 28, 2023.
90. Smith S. Kidney Cancer: Causes, Symptoms, Signs, Diagnosis, Treatments, Stages of Kidney Cancer. Charleston, SC: CreateSpace; 2012.
91. American Cancer Society. Key Statistics About Bladder Cancer. Available at https://www.cancer.org/cancer/bladder-cancer/about/key-statistics.html. Last accessed June 28, 2023.
92. National Cancer Institute. Bladder Cancer Treatment (PDQ)–Health Professional Version. Available at https://www.cancer.gov/types/bladder/hp/bladder-treatment-pdq. Last accessed June 28, 2023.
93. Galvagno SM. Emergency Pathophysiology: Clinical Applications for Prehospital Care. Jackson, WY: Teton NewMedia; 2013.
95. Markovchick VJ, Pons PT, Bakes KM, Buchanan JA. Emergency Medicine Secrets. 6th ed. Philadelphia, PA: Elsevier; 2016.
96. Goldstein RS. Mechanisms of Injury in Renal Disease and Toxicity. Boca Raton, FL: CRC Press; 1994.
97. KDOQI Clinical Practice Guidelines for vascular access. Am J Kidney Dis. 2006;48(Suppl 1):S176-S247.
98. Beathard G. A practitioner's resource guide to hemodialysis arteriovenous fistulas. ESRD Network of Texas. 2003;(Suppl).
99. Lomonte C, Basile C. Preoperative assessment and planning of hemodialysis vascular access. Clin Kidney J. 2015;8(3):278-281.
100. Santoro D, Benedetto F, Mondello P, et al. Vascular access for hemodialysis: current perspectives. Int J Nephrol Renovasc Dis. 2014;7:284-294.
101. Drew DA, Lok CE. Strategies for planning the optimal dialysis access for an individual patient. Curr Opin Nephrol Hypertens. 2014;23(3):314-320.
102. Tordoir JH, Bode AS, van Loon MM. Preferred strategy for hemodialysis in access creation in elderly patients. Eur J Vasc Endovasc Surg. 2015;49(6):738-743.
103. Mansilla AV, Toombs BD, Vaughn WK, Zeledon JI. Patency and life-spans of failing hemodialysis grafts in patients undergoing repeated percutaneous de-clotting. Tex Heart Inst J. 2001;28(4):249-253.
104. Zaleski G. Declotting, maintenance, and avoiding procedural complications of native arteriovenous fistulae. Semin Intervent Radiol. 2004;21(2):83-93.
105. Centers for Medicare and Medicaid Services. Center for Clinical Standards and Quality. CMS ESRD Measured Manual for the 2018 Performance Period/2020 Payment Year v3.0. Available at https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/ESRDQIP/Downloads/ESRD-Manual-v30.pdf. Last accessed June 28, 2023.
106. Hagen SM, Lafranca JA, Ijzemans JN, Dor FJ. A systematic review and meta-analysis of the influence of peritoneal dialysis catheter type on complication rate and catheter survival. Kidney Int. 2014;85(4):920-932.
107. Lye WC, Kour NW, van der Straaten JC, Leong SO, Lee EJ. A prospective randomized comparison of the Swan neck, coiled, and straight Tenckhoff catheters in patients on CAPD. Perit Dial Int. 1996;16(Suppl 1):S333-S335.
108. Xie J, Kiryluk K, Ren H, et al. Coiled versus straight peritoneal dialysis catheters: a randomized controlled trial and meta-analysis.Am J Kidney Dis. 2011;58(6):946-955.
109. National Institute of Diabetes and Digestive and Kidney Diseases. Kidney Disease Statistics for the United States. Available at https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease. Last accessed June 28, 2023.
110. Stock PG, Barin B, Murphy B, et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med. 2010;363(21):2004-2014.
111. Organ Procurement and Transplantation Network. Policies: Allocation of Kidneys. Available at https://optn.transplant.hrsa.gov/media/1200/optn_policies.pdf. Last accessed June 28, 2023.
112. Organ Procurement and Transplantation Network. Kidney Allocation System. Available at https://optn.transplant.hrsa.gov/learn/professional-education/kidney-allocation-system. Last accessed June 28, 2023.
113. Tapiawala SN, Tinckam KJ, Cardella CJ, et al. Delayed graft function and the risk for death with a functioning graft. J Am Soc Nephrol. 2010;21(1):153-161.
114. Curtis JR. Palliative and end-of-life care for patients with severe COPD. Eur Respir J. 2008;32(3):796-803.
115. Renal Physicians Association. Shared Decision-Making in the Appropriate Initiation and Withdrawal from Dialysis. Clinical Practice Guideline. 2nd ed. Rockville, MD: Renal Physicians Association; 2010.
116. Larson AM, Curtis JR. Integrating palliative care for liver transplant candidates: "too well for transplant, too sick for life." JAMA. 2006;295(108):2168-2176.
117. U.S. Centers for Medicare and Medicaid Services. Hospice Determining Terminal Status. Available at https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=34538. Last accessed June 28, 2023.
118. Clayton JM, Hancock KM, Butow PN, et al. Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers. Med J Aust. 2007;188(12 Suppl):S77, S79, S83-S108.
119. Buckman R. Communication skills in palliative care: a practical guide. Neurol Clin. 2001;19(4):989-1004.
120. Finlay E, Casarett D. Making difficult decisions easier: using prognosis to facilitate transitions to hospice. Ca Cancer J Clin. 2009;59:250-263.
121. Stapleton R, Curtis JR. End-of-life considerations in older patients who have lung disease. Clin Chest Med. 2007;28(4):801-811.
122. Silveira MJ, Kim SY, Langa KM. Advance directives and outcomes of surrogate decision making before death. N Engl J Med. 2010;362(13):1211-1218.
123. Goodlin SJ. Palliative care in congestive heart failure. J Am Coll Cardiol. 2009;54(5):386-396.
124. Lee D, Lee S, Choe H. Community-acquired urinary tract infection by Escherichia coli in the era of antibiotic resistance. Biomed Res Int. 2018;2018:7656752.
125. Schoener B, Borger J. Erythropoietin-stimulating agents. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2023.
126. Ajib F, Childress J. Magnesium toxicity. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2023.
127. Cascella M, Vaqar S. Hypermagnesemia. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2023.
128. Kato S, Chmielewski M, Honda H, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008;3(5):1526-1533.
129. Avin KG, Moorthi RN. Bone is not alone: the effects of skeletal muscle dysfunction in chronic kidney disease. Curr Osteoporos Rep. 2015;13(3):173-179.
130. Pagonas N, Vautz W, Seifert L, et al. Volatile organic compounds in uremia. PLoS ONE. 2012;7(9):e46258.
131. Nicholas SB, Kalantar-Zadeh K, Norris KC. Socioeconomic disparities in chronic kidney disease. Adv Chronic Kidney Dis. 2015;22(1):6-15.
132. Hallab A, Wish JB. Employment among patients on dialysis: an unfulfilled promise. Clin J Am Soc Nephrol. 2018;13(2):203-204.
133. Eastham J, Patel P. Phenazopyridine. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2023.
134. Arinzon Z, Shabat S, Peisakh A, Berner Y. Clinical presentation of urinary tract infection (UTI) differs with aging in women. Archives of Gerontology and Geriatrics. 2012;55(1):145-147.
135. Urinalysis: Reference Range, Interpretation, Collection and Panels. Available at https://emedicine.medscape.com/article/2074001-overview. Last accessed June 28, 2023.
136. Simon L, Sajjad H, Lopez R, et al. Bladder rupture. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2023.
137. Licina A. Acute abdominal compartment syndrome following extraperitoneal bladder perforation. Case Reports in Anesthesiology. 2017;2017:1-5.
138. U.S. Renal Data System. 2021 Annual Data Report. Available at https://www.supremecourt.gov/opinions/URLs_Cited/OT2021/20-1641/20-1641-1.pdf. Last accessed June 28, 2023.
139. U.S. Renal Data Reporting System. Chronic Kidney Disease: Chapter 4. Available at https://usrds-adr.niddk.nih.gov/2022/chronic-kidney-disease/4-acute-kidney-injury/#figure-4-1-section-wrapper. Last accessed June 28, 2023.
140. Lim Y, Leslie S, O'Rourke S. Interstitial cystitis. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2023.
141. Velez R, Richmond E, Dudley-Brown S. Antibiogram, clinical practice guidelines, and treatment of urinary tract infection. Journal for Nurse Practitioners. 2017;13(9):617-622.
142. Fontenelle LF, Sarti TD. Kidney stones: treatment and prevention. Am Fam Physician. 2019;99(8):490-496.
143. National Institute of Diabetes and Digestive and Kidney Diseases. Kidney Disease Statistics for the United States. Available at https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease. Last accessed June 28, 2023.
144. United Network for Organ Sharing. 2022 Organ Transplants Again Set Annual Records. Available from https://optn.transplant.hrsa.gov/media/njsllhg4/policy-notice_egfrwtmods_mac_ki.pdf. Last accessed June 28, 2023.
145. Dreyer GJ, de Fijter JW. Transplanting the elderly: mandatory age- and minimal histocompatibility matching. Frontiers in Immunology. 2020;11.
146. Strohmaier S, Wallisch C, Kammer M, et al. Survival benefit of first single-organ deceased donor kidney transplantation compared with long-term dialysis across ages in transplant-eligible patients with kidney failure. JAMA Network Open. 2022;5(10):e2234971.
147. Penn Medicine. Too Many Donor Kidneys Are Discarded in U.S. Before Transplantation. Available at https://www.pennmedicine.org/news/news-releases/2020/december/too-many-donor-kidneys-are-discarded-in-us-before-transplantation. Last accessed June 28, 2023.
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.